-
1
-
-
0025324294
-
Differential susceptibility to DL-α-difluoromethylornithine in clinical isolates of Trypanosoma brucei rhodesiense
-
Bacchi, C. J., Nathan, H. C., Livingston,T.,Valladares, G., Saric, M., Sayer, P. D., Njogu, A. R. & Clarkson, A. B. (1990). Differential susceptibility to DL-α-difluoromethylornithine in clinical isolates of Trypanosoma brucei rhodesiense. Antimicrobial Agents and Chemotherapy, 34, 1183-1188.
-
(1990)
Antimicrobial Agents and Chemotherapy
, vol.34
, pp. 1183-1188
-
-
Bacchi, C.J.1
Nathan, H.C.2
Livingston, T.3
Valladares, G.4
Saric, M.5
Sayer, P.D.6
Njogu, A.R.7
Clarkson, A.B.8
-
2
-
-
0024420897
-
Treatment of arsenical refractory Rhodesian sleeping sickness in Kenya
-
Dales, J. D., Harrison, S. M. & Mwabi, D. L. (1989). Treatment of arsenical refractory Rhodesian sleeping sickness in Kenya. Annals of Tropical Medicine and Parasitology, 83, supplement 1, 111-114.
-
(1989)
Annals of Tropical Medicine and Parasitology
, vol.83
, Issue.SUPPL. 1
, pp. 111-114
-
-
Dales, J.D.1
Harrison, S.M.2
Mwabi, D.L.3
-
3
-
-
0030824384
-
Alteration in ornithine decarboxylase characteristics account for tolerance of Trypanosoma brucei rhodesiense to DL-α-difluoromethylornithine (DFMO)
-
Iten, M., Met, H., Evans, A., Engau, J. C., Brun, R. & Kaminsky, R. (1997). Alteration in ornithine decarboxylase characteristics account for tolerance of Trypanosoma brucei rhodesiense to DL-α-difluoromethylornithine (DFMO). Antimicrobial Agents and Chemotherapy, 41, 1922-1925.
-
(1997)
Antimicrobial Agents and Chemotherapy
, vol.41
, pp. 1922-1925
-
-
Iten, M.1
Met, H.2
Evans, A.3
Engau, J.C.4
Brun, R.5
Kaminsky, R.6
-
4
-
-
0026660462
-
Efficacy and toxicity of eflornithine for treatment of Trypanosoma brucei gambiense sleeping sickness
-
Milord, F., Pépin, J., Loko, L., Ethier, L. & Mpia, B. (1992). Efficacy and toxicity of eflornithine for treatment of Trypanosoma brucei gambiense sleeping sickness. Lancet, 340, 652-655.
-
(1992)
Lancet
, vol.340
, pp. 652-655
-
-
Milord, F.1
Pépin, J.2
Loko, L.3
Ethier, L.4
Mpia, B.5
-
5
-
-
0023633450
-
Difluoromethylornithine, an effective new treatment of Gambian trypanosomiasis
-
Taelman, H., Schechter, P. J., Marcelis, L., Sonnet, J., Kayumva, G., Dasnoy, J., Haegele, K. D., Sjoerdsma, A. & Wéry, M. (1987). Difluoromethylornithine, an effective new treatment of Gambian trypanosomiasis. Results in five patients. American Journal of Medicine, 82, 607-614.
-
(1987)
Results in Five Patients. American Journal of Medicine
, vol.82
, pp. 607-614
-
-
Taelman, H.1
Schechter, P.J.2
Marcelis, L.3
Sonnet, J.4
Kayumva, G.5
Dasnoy, J.6
Haegele, K.D.7
Sjoerdsma, A.8
Wéry, M.9
-
6
-
-
0029858681
-
-
Taelman, H., Clerinx, J., Bogaerts, J. & Vervoort, T. (1996). Combination treatment with suramin and eflornithine in late stage rhodesian trypanosomiasis: case report: Transactions of the Royal Society of Tropical Medicine and Hygiene, 90, 572-573.
-
(1996)
Combination Treatment with Suramin and Eflornithine in Late Stage Rhodesian Trypanosomiasis: Case Report: Transactions of the Royal Society of Tropical Medicine and Hygiene
, vol.90
, pp. 572-573
-
-
Taelman, H.1
Clerinx, J.2
Bogaerts, J.3
Vervoort, T.4
|